Logo image of SEAT

VIVID SEATS INC - CLASS A (SEAT) Stock Fundamental Analysis

USA - NASDAQ:SEAT - US92854T2096 - Common Stock

10.7 USD
-1 (-8.55%)
Last: 10/17/2025, 8:00:02 PM
10.7 USD
0 (0%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SEAT. SEAT was compared to 79 industry peers in the Entertainment industry. SEAT may be in some trouble as it scores bad on both profitability and health. SEAT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SEAT had positive earnings in the past year.
SEAT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SEAT reported negative net income in multiple years.
Of the past 5 years SEAT 4 years had a positive operating cash flow.
SEAT Yearly Net Income VS EBIT VS OCF VS FCFSEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.29%, SEAT is doing worse than 74.68% of the companies in the same industry.
Looking at the Return On Equity, with a value of -64.97%, SEAT is doing worse than 70.89% of the companies in the same industry.
Industry RankSector Rank
ROA -12.29%
ROE -64.97%
ROIC N/A
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEAT Yearly ROA, ROE, ROICSEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

SEAT's Operating Margin has declined in the last couple of years.
The Gross Margin of SEAT (72.56%) is better than 84.81% of its industry peers.
In the last couple of years the Gross Margin of SEAT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SEAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.56%
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
SEAT Yearly Profit, Operating, Gross MarginsSEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

1

2. Health

2.1 Basic Checks

SEAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEAT has about the same amount of shares outstanding.
Compared to 5 years ago, SEAT has less shares outstanding
The debt/assets ratio for SEAT is higher compared to a year ago.
SEAT Yearly Shares OutstandingSEAT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEAT Yearly Total Debt VS Total AssetsSEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SEAT has an Altman-Z score of -0.74. This is a bad value and indicates that SEAT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.74, SEAT is doing worse than 70.89% of the companies in the same industry.
SEAT has a Debt/Equity ratio of 1.77. This is a high value indicating a heavy dependency on external financing.
SEAT has a Debt to Equity ratio of 1.77. This is in the lower half of the industry: SEAT underperforms 73.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF N/A
Altman-Z -0.74
ROIC/WACCN/A
WACC5.77%
SEAT Yearly LT Debt VS Equity VS FCFSEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

SEAT has a Current Ratio of 0.72. This is a bad value and indicates that SEAT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.72, SEAT is not doing good in the industry: 68.35% of the companies in the same industry are doing better.
A Quick Ratio of 0.63 indicates that SEAT may have some problems paying its short term obligations.
SEAT has a worse Quick ratio (0.63) than 73.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.63
SEAT Yearly Current Assets VS Current LiabilitesSEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.73% over the past year.
The Revenue for SEAT has decreased by -10.52% in the past year. This is quite bad
SEAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.59% yearly.
EPS 1Y (TTM)13.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1700%
Revenue 1Y (TTM)-10.52%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-27.61%

3.2 Future

Based on estimates for the next years, SEAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -32.45% on average per year.
SEAT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.05% yearly.
EPS Next Y-4407.33%
EPS Next 2Y-153.4%
EPS Next 3Y-83.76%
EPS Next 5Y-32.45%
Revenue Next Year-23.58%
Revenue Next 2Y-13.53%
Revenue Next 3Y-6.5%
Revenue Next 5Y-1.05%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SEAT Yearly Revenue VS EstimatesSEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SEAT Yearly EPS VS EstimatesSEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -10 -20

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.09 indicates a rather cheap valuation of SEAT.
Based on the Price/Earnings ratio, SEAT is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of SEAT to the average of the S&P500 Index (27.40), we can say SEAT is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 3.09
Fwd PE N/A
SEAT Price Earnings VS Forward Price EarningsSEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SEAT is valued cheaply inside the industry as 81.01% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.88
SEAT Per share dataSEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 -60

4.3 Compensation for Growth

SEAT's earnings are expected to decrease with -83.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-153.4%
EPS Next 3Y-83.76%

More info and screens

0

5. Dividend

5.1 Amount

SEAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIVID SEATS INC - CLASS A

NASDAQ:SEAT (10/17/2025, 8:00:02 PM)

After market: 10.7 0 (0%)

10.7

-1 (-8.55%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners79.16%
Inst Owner Change-0.02%
Ins Owners9.59%
Ins Owner Change0.77%
Market Cap110.53M
Analysts71.76
Price Target39.31 (267.38%)
Short Float %12.6%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.31%
Min EPS beat(2)-472.49%
Max EPS beat(2)541.12%
EPS beat(4)2
Avg EPS beat(4)6.18%
Min EPS beat(4)-472.49%
Max EPS beat(4)541.12%
EPS beat(8)4
Avg EPS beat(8)3.64%
EPS beat(12)7
Avg EPS beat(12)35.93%
EPS beat(16)11
Avg EPS beat(16)2999230%
Revenue beat(2)0
Avg Revenue beat(2)-6.33%
Min Revenue beat(2)-7.42%
Max Revenue beat(2)-5.24%
Revenue beat(4)1
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-7.42%
Max Revenue beat(4)0.87%
Revenue beat(8)4
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)5.06%
Revenue beat(16)12
Avg Revenue beat(16)8.34%
PT rev (1m)0%
PT rev (3m)1150.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4152.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-21358.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.18%
Valuation
Industry RankSector Rank
PE 3.09
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB N/A
EV/EBITDA 7.88
EPS(TTM)3.46
EY32.34%
EPS(NY)-2.56
Fwd EYN/A
FCF(TTM)-3.18
FCFYN/A
OCF(TTM)-2.45
OCFYN/A
SpS67.18
BVpS21.04
TBVpS-61.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.29%
ROE -64.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.56%
FCFM N/A
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.08%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF N/A
Debt/EBITDA 8.5
Cap/Depr 15.93%
Cap/Sales 1.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.63
Altman-Z -0.74
F-Score3
WACC5.77%
ROIC/WACCN/A
Cap/Depr(3y)22.81%
Cap/Depr(5y)24.24%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.53%
Profit Quality(3y)249.59%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1700%
EPS Next Y-4407.33%
EPS Next 2Y-153.4%
EPS Next 3Y-83.76%
EPS Next 5Y-32.45%
Revenue 1Y (TTM)-10.52%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-27.61%
Revenue Next Year-23.58%
Revenue Next 2Y-13.53%
Revenue Next 3Y-6.5%
Revenue Next 5Y-1.05%
EBIT growth 1Y-103.28%
EBIT growth 3Y-17.97%
EBIT growth 5YN/A
EBIT Next Year6.74%
EBIT Next 3Y15.47%
EBIT Next 5Y18.96%
FCF growth 1Y-135.57%
FCF growth 3Y-34.7%
FCF growth 5Y-8.36%
OCF growth 1Y-126.48%
OCF growth 3Y-32.56%
OCF growth 5Y-6.76%